Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT Study
Clinical trial update on the IUS-TTT study evaluating the role of intestinal ultrasound in a treat-to-target strategy for inflammatory bowel…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Comparing TRIple Rectal Ultrasound Imaging Technology in Ulcerative Colitis [NA]
A completed clinical trial evaluating TRIple Rectal Ultrasound Imaging Technology in patients with Ulcerative Colitis.
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis [EARLY_Phase 1]
A Phase 1 clinical trial is evaluating the safety and potential efficacy of empagliflozin in patients with ulcerative colitis; the study is …
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease
The Cleveland Clinic reports an active-not-recruiting clinical trial investigating volatile organic compounds in active inflammatory bowel d…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
A long-term registry update on the use of Humira (adalimumab) for patients with moderately to severely active ulcerative colitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis [Phase 2]
Pfizer-sponsored Phase 2 trial comparing etrasimod to placebo in moderately active ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2025-07-14Clinical Trial Update: Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating empagliflozin as adjuvant therapy for ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC) [NA]
A clinical trial update for ENC1018 capsules evaluating safety, pharmacokinetics, and preliminary efficacy in moderate-to-severe active ulce…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis [Phase 4]
This clinical trial update outlines a Phase 4 study evaluating mirikizumab for Crohn's disease and ulcerative colitis in adults over 60. The…
-
CLINICAL_TRIALS withdrawal · 2025-07-09Clinical Trial Update: Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway [NA]
Clinical trial evaluating an inflammatory bowel disease biologic care pathway to improve patient outcomes has been withdrawn. The study targ…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Ten Versus Fifteen Centimeter Pouch in IPAA Surgery [NA]
This clinical trial compares 10 cm versus 15 cm ileal pouch length in ileal pouch-anal anastomosis (IPAA) surgery. It targets patients with …
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Mirikizumab Real World Protocol
A real-world protocol study evaluating mirikizumab for ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: IBD Strong Peer2Peer for Self-Management of Psychological Distress [NA]
This clinical trial update notes a study called IBD Strong Peer2Peer aimed at self-management of psychological distress in inflammatory bowe…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Vitamin D and Disease Activity in Ulcerative Colitis
This update notes the University of Chicago’s completed clinical trial assessing the relationship between vitamin D and disease activity in …
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: BOOM-IBD2 Pivotal Clinical Trial [NA]
Boomerang Medical’s BOOM-IBD2 pivotal clinical trial for ulcerative colitis and inflammatory bowel disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis
A clinical trial update examining factors that influence the selection and effectiveness of first-line biologic therapies for moderate-to-se…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis
This ClinicalTrials.gov update indicates that the study evaluating ozanimod for ulcerative colitis has been terminated, reporting on utiliza…
-
FDA approval · 2025-07-01FDA Approved: MESALAMINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for Mesalamine from Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis [Phase 2]
AbbVie’s Phase 2 trial evaluating oral NX-13 for moderate to severe ulcerative colitis was terminated.
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Randomized Controlled Trial Comparing Remote Patient Monitoring vs Standard Care in IBD Patients Initiating or Changing Advanced Therapy [Phase 3]
A Phase 3 randomized trial is evaluating remote patient monitoring versus standard care for inflammatory bowel disease patients initiating o…
-
FDA label_change · 2025-06-27FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approves a supplemental application for Ustekinumab (Stelara) by Janssen Biotech, resulting in updated labeling.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Nitazoxanide in Patients With Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating nitazoxanide for ulcerative colitis is currently recruiting at Alexandria University.
-
FDA approval · 2025-06-26FDA Approved: MERCAPTOPURINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for mercaptopurine, enabling continued marketing of the generic p…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 safety study of Lactobacillus reuteri BGP-014 in patients with Ulcerative C…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating SPH3127 in mild-to-moderate ulcerative colitis was terminated, with results posted on ClinicalTrials.gov on 2025-06…